Commerzbank’s Dual Test: Earnings Day Arrives as Weidmann’s Olive Branch Reshapes the Takeover Chessboard
Published on 07/25/2026 at 10:12 | Redaktion boerse-global.deCommerzbank enters a defining week with two narratives colliding. On August 6, the lender will publish its second-quarter results, the first hard evidence of whether its upgraded full-year guidance holds water. But the numbers will land in a radically altered strategic landscape: just days earlier, supervisory board chairman Jens Weidmann publicly invited UniCredit to formal talks, ending months of resistance.
The shift in tone is stark. Weidmann, who had long kept the Italian bank at arm’s length, told Handelsblatt that both the management board and supervisory board had repeatedly signaled their readiness to negotiate. He acknowledged that the voting arithmetic at the next annual general meeting is now clear, given UniCredit’s creeping stake. Through its tender offer and additional call options, the Milan-based lender is closing in on roughly half of Commerzbank’s shares. Yet Weidmann drew a firm line: there will be no “shortcut via Berlin” for the remaining government stake.
The German finance ministry is keeping its distance, stating that it is now up to the two banks to talk. The numbers from the extended acceptance period, which ended July 3, tell their own story. Just 17.6 percent of shares were tendered, with institutional and retail investors together contributing less than 2 percent. Commerzbank interprets the low participation as evidence that independent shareholders find the offer unattractive. LBBW analyst Werner Schirmer sees a long road ahead, noting that a merger with UniCredit’s HypoVereinsbank subsidiary is “apparently not planned for the next three years.”
The stock closed Friday at €36.60, up 0.83 percent on the day but down 0.41 percent over the week and 2.27 percent over the past month. That leaves it 6.58 percent below the year’s high of €39.18, hit on July 14. The next technical target sits at the ten-year peak of €38.77 from the same date, implying roughly 7 percent upside. The consensus from 60 analysts points to a target of €35.53, suggesting a slight overvaluation, while a smaller survey of seven houses is far more bullish at €39.63.
Should investors sell immediately? Or is it worth buying Commerzbank?
The Earnings Pivot Point
The August 6 release will test whether the upgraded net interest income forecast — which prompted RBC Capital Markets and others to adjust their models — is backed by operational reality. More important than the headline profit figure will be whether the higher interest income outlook holds up against credit losses and competitive pressure in retail banking.
Chartists see a market in limbo. The stock trades 1.63 percent below its 50-day moving average of €37.21, with a relative strength index of 44.5 — neutral territory that signals no clear directional momentum. The annualized 30-day volatility of 28.35 percent adds to the sense of nervous trading.
The bull case rests on the fundamental improvement. Management has already raised its own guidance, typically a vote of confidence in the operating trajectory. The bank’s recent accolade at the FINANCE Awards 2026, where it was named Germany’s best corporate banking house with nine first-place finishes across lending, cash management, and digitalization, underscores the strength of its standalone strategy. Over twelve months, the stock is up 21.92 percent, and it trades 5.28 percent above its 200-day moving average of €34.77 — a 26.16 percent premium to the 52-week low of €29.01.
The bear case warns that expectations have been set high. Even solid numbers could trigger a “sell the news” reaction if the market has already priced in the upgrade. Structural uncertainty around the shareholder base adds another layer of risk. A clean break below the 50-day line, combined with a disappointing earnings report, could deepen the consolidation and push the year’s high far out of reach.
The Broader German Banking Drama
Commerzbank is not the only German lender navigating turbulence. Deutsche Pfandbriefbank remains one of the most heavily shorted bank stocks in the country, with funds including Caius Capital, SIH Partners, and Wellington Management maintaining large bearish positions. The stock has been under pressure since a near-12 percent drop in June, which briefly pushed it to around €3.20. It closed Friday at €3.44, up 0.41 percent, after falling below its 50-day moving average the previous day. At a price-to-earnings ratio of 36.36, the valuation looks stretched, though a dividend yield of 4.41 percent offers some comfort. A supervisory board reshuffle — Louis Hagen departing, Jan Kupfer set to take over as chairman — adds another layer of uncertainty.
Commerzbank at a turning point? This analysis reveals what investors need to know now.
The contrast between the two German banks is instructive. Commerzbank spent months fending off a suitor; pbb is fighting structural short sellers tied to its commercial real estate exposure. Both face pivotal moments, but from opposite directions.
What Comes Next
For Commerzbank, the next fortnight will determine whether Weidmann’s diplomatic opening translates into a credible negotiation framework with UniCredit — and how the remaining government stake factors into discussions on jobs, locations, and the stock exchange listing. The earnings report on August 6 will either validate the upgraded guidance and give the board leverage, or expose vulnerabilities that strengthen UniCredit’s hand.
Until then, the stock’s relationship with its 50-day moving average will serve as a daily proxy for market sentiment. A decisive reclaim of that level, backed by strong quarterly numbers, would reopen the path to the year’s high. A failure to do so would confirm that the post-July consolidation has further to run — and that the takeover drama is far from resolved.
Ad
Commerzbank Stock: New Analysis - 25 July
Fresh Commerzbank information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
